Current status of stem cell therapy in heart failure

Current Cardiology Reports

Volumn 12, Issue 3, 2010, Pages 199-208

  Codina, Marta ^a   Elser, Jeremy ^a   Margulies, Kenneth B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone marrow cells; Endogenous cardiac repair; Progenitor cells; Stem cell therapy; Tissue engineering

Indexed keywords

CONNEXIN 43; GRANULOCYTE COLONY STIMULATING FACTOR; NERVE CELL ADHESION MOLECULE; SOMATOMEDIN C; STEM CELL FACTOR RECEPTOR; TISSUE SCAFFOLD;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANGIOGENESIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART TRANSPLANTATION; HUMAN; HYDROGEL; MAMMAL; MEDICAL RESEARCH; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PROTEIN EXPRESSION; REVIEW; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; TRANSLUMINAL CORONARY ANGIOPLASTY;

BONE MARROW TRANSPLANTATION; HEART FAILURE; HUMANS; MUSCLE CELLS; MYOBLASTS; MYOCARDIUM; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 77956394094     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-010-0098-5     Document Type: Review

References (50)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. : Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21-e181.
2. Glaser R, Lu MM, Narula N, Epstein JA: Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 2002, 106:17-19.
3. Hocht-Zeisberg E, Kahnert H, Guan K, et al.: Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation. Eur Heart J 2004, 25:749-758.
4. Urbanek K, Torella D, Sheikh F, et al.: Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A 2005, 102:8692-8697.
5. Angelini P, Markwald RR: Stem cell treatment of the heart: A review of its current status on the brink of clinical experimentation. Tex Heart Inst J 2005, 32:479-488.
6. Leri A, Kajstura J, Anversa P: Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 2005, 85:1373-1416.
7. Kajstura J, Rota M, Whang B, et al.: Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005, 96:127-137.
8. Murry CE, Soonpaa MH, Reinecke H, et al.: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
9. Smith RR, Barile L, Cho HC, et al.: Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115:896-908. This is a study demonstrating isolation of c-kit expressing S/PCs from human heart biopsies. These cells are capable of proliferation, and capable of generating new functional cardiac myocytes in vitro or in vitro.
10. Balsam LB, Wagers AJ, Christensen JL, et al.: Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
11. Fazel S, Cimini M, Chen L, et al.: Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006, 116:1865-1877.
12. Hsieh PC, Segers VF, Davis ME, et al.: Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 2007, 13:970-974.
13. Bergmann O, Bhardwaj RD, Bernard S, et al.: Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102. This is a novel quantitative demonstration of new cardiac myocyte formation in the adult human heart by exploiting fluxes in atmospheric radiation induced by an era of nuclear testing.
14. Kubo H, Jaleel N, Kumarapeli A, et al.: Increased cardiac myocyte progenitors in failing human hearts. Circulation 2008, 118:649-657. This is a study demonstrating that S/PCs expressing c-kit can be isolated from virtually all human hearts, are more abundant in failing hearts, and can be induced to differentiate into immature cardiac myocytes.
15. Menasche P, Alfieri O, Janssens S, et al.: The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
16. Raible E: MARVEL-1: Autologous myoblast transplantation linked with slight improvements in congestive HF. Cardiology Today 2009, 12:1.
17. Valgimigli M, Rigolin GM, Cittanti C, et al.: Use of granulocytecolony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: Clinical and angiographic safety profile. Eur Heart J 2005, 26:1838-1845.
18. Ripa RS, Jorgensen E, Wang Y, et al.: Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: Result of the double-blind, randomized, placebocontrolled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006, 113:1983-1992.
19. Zohlnhofer D, Dibra A, Koppara T, et al.: Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: A meta-analysis. J Am Coll Cardiol 2008, 51:1429-1437.
20. Dill T, Schachinger V, Rolf A, et al.: Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute STsegment elevation myocardial infarction: Results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Am Heart J 2009, 157:541-547.
21. Meyer GP, Wollert KC, Lotz J, et al.: Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' followup data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006, 113:1287-1294.
22. Martin-Rendon E, Brunskill SJ, Hyde CJ, et al.: Autologous bone marrow stem cells to treat acute myocardial infarction: A systematic review. Eur Heart J 2008, 29:1807-1818. This is a meta-analysis of all multiple clinical trials administering autologous bone marrow-derived stem cells in the setting of acute MI.
23. Lunde K, Solheim S, Forfang K, et al.: Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: Safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up. J Am Coll Cardiol 2008, 51:674-676.
24. Yousef M, Schannwell CM, Kostering M, et al.: The BALANCE Study: Clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol 2009, 53:2262-2269.
25. Gyongyosi M, Lang I, Dettke M, et al.: Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: The MYSTAR prospective, randomized study. Nat Clin Pract Cardiovasc Med 2009, 6:70-81.
26. Chen SL, Fang WW, Ye F, et al.: Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004, 94:92-95.
27. Katritsis DG, Sotiropoulou PA, Karvouni E, et al.: Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 2005, 65:321-329.
28. Bartunek J, Vanderheyden M, Vandekerckhove B, et al.: Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: Feasibility and safety. Circulation 2005, 112:1178-1183.
29. Hofmann M, Wollert KC, Meyer GP, et al.: Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111:2198-2202.
30. Qiao H, Surti S, Choi SR, et al.: Death and proliferation time course of stem cells transplanted in the myocardium. Mol Imaging Biol 2009, 11:408-414. This is a carefully executed animal study using labeling, imaging, and molecular techniques to demonstrate the fate of administered S/PCs after in vivo implantation.
31. Kelly DJ, Rosen AB, Schuldt AJ, et al.: Increased myocyte content and mechanical function within a tissue-engineered myocardial patch following implantation. Tissue Eng Part A 2009, 15:2189-2201.
32. Dai W, Hale SL, Kay GL, et al.: Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen Med 2009, 4:387-395.
33. Suuronen EJ, Zhang P, Kuraitis D, et al.: An acellular matrixbound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model. FASEB J 2009, 23:1447-1458.
34. Padin-Iruegas ME, Misao Y, Davis ME, et al.: Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation 2009, 120:876-887. This is an excellent study demonstrating that endogenous and exogenous S/PC-mediated cardiac repair can be enhanced by concomitant delivery of customized nanofibers that increase local levels of IGF-1.
35. Fink C, Ergun S, Kralisch D, et al.: Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J 2000, 14:669-679.
36. O'Cearbhaill ED, Punchard MA, Murphy M, et al.: Response of mesenchymal stem cells to the biomechanical environment of the endothelium on a flexible tubular silicone substrate. Biomaterials 2008, 29:1610-1619.
37. Engler AJ, Sen S, Sweeney HL, Discher DE: Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
38. Geisse NA, Sheehy SP, Parker KK: Control of myocyte remodeling in vitro with engineered substrates. In Vitro Cell Dev Biol Anim 2009, 45:343-350.
39. Ferreira LS, Gerecht S, Fuller J, et al.: Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 2007, 28:2706-2717.
40. Kobayashi H, Shimizu T, Yamato M, et al.: Fibroblast sheets cocultured with endothelial progenitor cells improve cardiac function of infarcted hearts. J Artif Organs 2008, 11:141-147. This is a study demonstrating that a sheet-like engineered tissue construct consisting of endothelial progenitors, fibroblasts, and a collagen matrix can increase angiogenesis, increase contractility, and reduce infarct size in experimental MI in rats.
41. Lesman A, Habib M, Caspi O, et al.: Transplantation of a tissueengineered human vascularized cardiac muscle. Tissue Eng Part A 2010, 16:115-125.
42. Ott HC, Matthiesen TS, Goh SK, et al.: Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14:213-221. This is an interesting study showing that decellularized rat hearts can be repopulated with neonatal myocytes and vascular cells to produce a beating heart. This demonstrates the importance of anatomic templates in tissue engineering and raises the possibility of future xenotransplantation applications.
43. Montoya CV, McFetridge PS: Preparation of ex vivo-based biomaterials using convective flow decellularization. Tissue Eng Part C Methods 2009, 15:191-200.
44. Radisic M, Marsano A, Maidhof R, et al.: Cardiac tissue engineering using perfusion bioreactor systems. Nat Protoc 2008, 3:719-738.
45. Tuzlakoglu K, Reis RL: Biodegradable polymeric fiber structures in tissue engineering. Tissue Eng Part B Rev 2009, 15:17-27.
46. Wu KH, Mo XM, Liu YL: Cell sheet engineering for the injured heart. Med Hypotheses 2008, 71:700-702.
47. Masuda S, Shimizu T, Yamato M, Okano T: Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev 2008, 60:277-285.
48. Stevens KR, Pabon L, Muskheli V, Murry CE: Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A 2009, 15:1211-1222.
49. Brown MA, Iyer RK, Radisic M: Pulsatile perfusion bioreactor for cardiac tissue engineering. Biotechnol Prog 2008, 24:907-920.
50. Radisic M, Fast VG, Sharifov OF, et al.: Optical mapping of impulse propagation in engineered cardiac tissue. Tissue Eng Part A 2009, 15:851-860.